Condition: Opioid-use Disorder · Substance Use Disorders · Sponsor: InSightec
The purpose of this clinical trial is to investigate Low Intensity Focused Ultrasound (LIFU) using the Exablate® Model 4000 Type 2.0/2.1 as an adjunctive neuromodulatory treatment for OUD (Opioid Use Disorder) and/or other Substance Use Disorders (SUDs) by assessing its safety and tolerability in subjects with OUD.
This description comes directly from the study's public registry record.
Kingsley Nwaogu · 2143048264 · clinicalresearchquestions@insightec.com
Julia Zhu · clinicalresearchquestions@insightec.com
Always discuss trial participation with your own doctor first.
| Tampa General Hospital | Tampa, Florida, United States | Not Yet Recruiting |
| University of Maryland, Baltimore | Baltimore, Maryland, United States | Recruiting |
| Weill Cornell Medicine | New York, New York, United States | Recruiting |
| West Virginia University: Rockefeller Neuroscience Institute | Morgantown, West Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04197921